Literature DB >> 31558929

Histo-epidemiological aspects of gynecological and breast cancers at the University Teaching Hospital of Yaoundé.

Armand Duclaire Djimeli Kemo1, Blaise Nkegoum2, Charlette Nangue2, Félicité Djuikwo3, Landry Beyala Bita'a4, Pierre Marie Tebeu5.   

Abstract

INTRODUCTION: Cancer is a public health problem that affect women more than men. The aim of the study was to describe the epidemiological and histopathological features of gynecological malignancies in the city of Yaoundé, Cameroon.
METHODS: This was a descriptive cross-sectional study of histologically proven gynecological cancers over a 10-year period (2008-2017) in the Gynecology and Pathological Anatomy Departments of the University Teaching Hospital of Yaoundé.
RESULTS: A total of 682 cancers were identified among which, 342 gynecological cancers, for an overall frequency of 50.1% and an annual frequency of 34.2 cases on average. There was a trend suggesting an increase annual frequency over time. The cervix was the most frequent location with 182 cases (53.2%); followed by breast with 96 cases (28.1%); endometrium with 33 cases (9.7%) and ovaries 15 cases (4.4%). These patients were on average 51.9±13.7 years old, mostly housewives (56.8%), married (60.4%), multiparous (61.3%) and referred (62.6%). Histopathologically, cervical cancer was predominantly squamous cell carcinoma (86.8%), invasive (80.9%) and well differentiated (45.5%). For breast cancers, the majority were ductal carcinomas (78.1%), invasive (92%), and histological grade SBR II (50.6%). The most common histopathological types of endometrial and ovarian cancer were adenocarcinoma (72.2%) and serous cystadenocarcinoma (46.7%), respectively.
CONCLUSION: Gynecological cancers are common. Screening is expected to increase at 30 years for cervical cancer and start at age 40 with mammography for breast cancer.

Entities:  

Keywords:  Cameroon; Gynecological cancers; Yaoundé; epidemiology; histopathology

Mesh:

Year:  2019        PMID: 31558929      PMCID: PMC6754847          DOI: 10.11604/pamj.2019.33.130.18874

Source DB:  PubMed          Journal:  Pan Afr Med J


Introduction

Cancer is a group of serious diseases, fatal in the absence of effective treatment, characterized by a rapid and uncontrolled proliferation of abnormal cells that can affect any part of the body. When it touches the breast, the ovary or an organ of the genital tract, it is called gynecological cancer. Breast cancer is the most common cancer in the world with 1.7 million new cases, including 522,000 deaths each year [1]. Cervical cancer ranks second among women's cancers worldwide with 528,000 new cases and 266,000 deaths in 2012. Gynecological cancers account for 41.3% of all cancers in Africa [2]. They are responsible for 56.2% of cancer deaths among women in Cameroon [3]. Several studies have been conducted on gynecological cancers in Africa in general and in Cameroon in particular; however, few of them have been carried out at the University Teaching Hospital of Yaoundé, yet it is a reference hospital involved in the diagnosis and treatment of cancers. Therefore, we proposed to conduct this study, to help strengthen the prevention of these cancers.

Methods

Institutional ethic committee of Université des Montagnes approved this study; authorization N°2018/002/UdM/PR/CIE and research authorization from the General Director of University Teaching Hospital of Yaoundé, was obtained for the realization of this study. This was a descriptive cross-sectional study carried out in the Gynecology-Obstetrics and Pathological Anatomy Departments of the University Teaching Hospital of Yaoundé over a period of 10 years from January 1, 2008 to December 31, 2017. The study material consisted of Gynecology-Obstetrics and Pathological Anatomy registers; medical records and individual data sheets. Sampling was non-probabilistic, consecutive and exhaustive of all histopathological findings and or medical records confirming the diagnosis of in situ or invasive cancer of the breast, ovary or any organ of the genital tract. The case selection profile is presented in Figure 1. The data collection procedure is presented in Figure 2. The data were analyzed using the Epi info 7.1.3.3 software; the variables studied were frequency, age, marital status, occupation, religion, place of residence, cancer site, histological type, invasive character or not, the degree of differentiation and the year of diagnosis.
Figure 1

File selection profile

Figure 2

Data collection procedure

File selection profile Data collection procedure

Results

Frequencies of gynecological cancers: during the study period, 682 cancers were diagnosed among which 342 were gynecological and breast cancers, leading to an overall frequency of 50.1%. The annual incidence of gynecological cancers was 34.2 cases on average (342/10). Distribution of gynecological cancers according to the affected organ: Figure 3 shows distribution of gynecological cancers according to the affected organ. Cervical cancer was the most common with 53.2% (182 cases), followed by breast cancer with 28.1% (96 cases).
Figure 3

distribution of gynecological cancers by organ

distribution of gynecological cancers by organ Distribution of gynecological cancers by year of diagnosis: distribution of gynecological cancers according to the year of diagnosis is shown in Table 1. The frequency of diagnosed gynecological cancers tended to increase from one year to another. The highest frequency was observed in 2016 with 23.7% (72) of cases, and the lowest frequency was observed in 2008 with 4.1% (14) cases.
Table 1

distribution of gynecological cancers by affected organ and year of diagnosis

Affected organsTotal
CervixBreastEndometriumOvaryOthers
Year of dg.n=182n=96n=33n=15n=16N=342
n%n%n%n%N%n%
2008073.8022.1039.10213.30000144.1
2009116.0077.3013.000000318.7226.4
2010084.4109.4026.1016.70000215.3
2011126.6097.3039.10526.70212.5318.2
2012179.3109.40515.20533.3016.33810.0
20132111.5048.20412.10213.30212.53313.7
2014147.8053.1039.100000212.5247.0
20152915.91011.50412.100000318.74614.3
20163921.52629.20515.200000212.57223.7
20172413.21312.5039.1006.7016.3417.3

(dg.: diagnostis)

distribution of gynecological cancers by affected organ and year of diagnosis (dg.: diagnostis) Distribution of patients by age group and affected organ: the distribution of patients by age group and affected organ is shown in Table 2. Cancers were more common in those who were 40 years old and above.
Table 2

distribution of patients by age group and affected organ (N=342)

Affected organsTotal
CervixBreastEndometriumOvaryOthers
Age (class)N=182N=96N=33N=15N=16N=342
n%n%N%N%N%n%
[20-30[052.8044.20412.10213.30000154.4
[30-40[2714.81414.6013.0016.804254713.7
[40-50[5429.73031.3026.10213.304259226.9
[50-60[3418.62425.01442.40533.30425.08123.7
[60-70[3117.01414.50618.20533.3016.35716.7
[70-80[3016.51010.40515.200000318.74814.0
[80-90[010.60000013.000000000020.6
distribution of patients by age group and affected organ (N=342) Distribution of patients by other socio-demographic characteristics: Table 3 shows that more than half of the patients were married (56.7%), housewives (60.4%) and Christian (64.9%) while less than half of the patients 51 (45.95%) resided in Yaoundé.
Table 3

distribution by other socio-semographic characteristics

CharacteristicsNumber (N=111)Percentage (%)
Marital statusMarried6356.7
Widow3027.1
Single1715.3
Divorcee010.9
ProfessionNo occupation6760.4
Official109.0
shopping119.9
farmer1210.8
Other119.9
ReligionCatholic4944.1
protestant2320.8
Muslim087.3
Other3127.9
ResidenceYaounde5145.9
Others4439.6
NA1614.5

(NA: Non Available)

distribution by other socio-semographic characteristics (NA: Non Available) Cervical cancer: the histological types, aggression and degree of differentiation of cervical cancers were presented in Table 4. Squamous cell carcinoma was the most common histological type accounting for 86.8% (158). Invasive cervical cancers were the most common in 80.9% of cases. Among invasive cancers, 45.5% were well differentiated and 37.1% were moderately differentiated.
Table 4

histopathological Charateristics of cervical cancer

CharacteristicsNumber (n)Percentage (%)
Histological type (N = 182)
Squamous cell carcinoma15886.8
Adenocarcinoma2111.7
Adenosquamous carcinoma010.5
Mesonephrotic adenocarcinoma010.5
Angiosarcoma010.5
Aggressiveness (N = 173)
Invasive14080.9
Microinvasive2011.6
In situ137.5
Degree of differentiation (N = 132)
Well differentiated6045.5
Moderately differentiated4937.1
Little differentiated2317.4
histopathological Charateristics of cervical cancer Breast cancer: the histological types, aggressiveness and grades of Scarff, Bloom and Richardson breast cancers were grouped together and are presented in Table 5. The ductal and lobular carcinomas were the most common with 78.1% (75/96) and 16.7% (16/96) respectively. The majority, 92%, were invasive cancers. Grade II of Scarff, Bloom and Richardson was the most common representing 50.6% (39) while Grades I and III accounted for 16.9% (13) and 32.5% (25) of cases, respectively of our series.
Table 5

histopathological characteristics of breast cancer

CharacteristicsNumber (n)Percentage (%)
Histological type (N = 96)
Ductal carcinoma7578,1
Lobular carcinoma1616,7
Medullary carcinoma022,1
Colloid carcinoma022,1
Adenoid cystic carcinoma011,0
Aggressiveness (N = 87)
Invasive8092,0
In situ078,0
Grade SBR (N=77)
SBR I1316,9
SBR II3950,6
SBR III2532,5

(SBR: Scarff Bloom Richardson )

histopathological characteristics of breast cancer (SBR: Scarff Bloom Richardson ) Cancer of the uterine body: the histological types of cancers of the uterine body were distributed as shown in Table 6. Adenocarcinoma was the most recovered histological type with a proportion of 72.2% (26/36); followed by choriocarcinoma 13.8% (5/36).
Table 6

distribution according to the histological types of cancer of the body of the uterus

Histological typeNumber (N=36)Percentage (%)
Adenocarcinoma2672.2
Choriocarcinoma0513.8
Clear cell carcinoma025.6
Carcinoma012.8
Leiomyosarcoma012.8
Stromal endometrial sarcoma012.8
distribution according to the histological types of cancer of the body of the uterus Ovarian cancer: the histological types of ovarian cancers are shown in Table 7. Serious cystadenocarcinoma was the most common histological type accounting for 46.7% (7/15), followed by mucinous cystadenocarcinoma 26.7% (4/15).
Table 7

distribution by histological type of ovarian cancer

Histological typeNumber (N=15)Percentage (%)
Serious cystadenocarcinoma0746.7
Mucinous cystadenocarcinoma0426.7
Clear cell adenocarcinoma0213.3
Burkitt's lymphoma0213.3
distribution by histological type of ovarian cancer Other cancers: eight cases of vaginal cancer were identified, of which 87.5% (7/8 cases) were squamous cell carcinoma and 12.5% (1/8) were embryonic rhabdomyosarcoma. All vulvar cancers (05 cases) were squamous cell carcinomas and all trunk cancers were adenocarcinomas.

Discussion

Epidemiological characteristics of gynecological cancers

Average annual incidence of gynecological cancers in our series was 34.2 cases on average (342/10), which is lower than the 94.2 cases per year found by Sando et al. in 2014 at the Gyneco-obstetrics and Pediatric Hospital of Yaoundé [4]. This difference can be explained by the fact that, Gyneco-obstetrics and Pediatric Hospital of Yaoundé is the national reference hospital in oncological gynecology, meaning that it has a greater attendance to which can be added the proximity between the latter and the Yaoundé General Hospital, which houses the Yaoundé Medical Oncology Reference Center. The distribution of gynecological cancers according to the year of diagnosis shows that the number of cancers diagnosed per a year tended to increase over time, with a peak frequency in 2016 for cervical cancers, ie 21.4% (39/182) and breast 27.1% (26/96). These results can be explained by the existence of a breast and cervical cancer screening unit at the University Teaching Hospital of Yaoundé since 2009 and the organization of a cervical and breast cancer screening campaign in 2016. In addition, it is likely that doctors increasing prescription of screening and histological examinations over this time period. The unavailability of trained personnel needed to perform this service (two gynecologists and a nurse); could explain the decrease in frequency observed in 2014. Regarding the distribution of gynecological cancers according to the affected organ, cervical cancer was the leading gynecological cancer accounting for 53.2% of cases, this predominance of cervical cancer was found by several authors, including Tebeu et al. in 2009, which found 57% in Maroua and Sando et al. in 2014, who found 49.5% at University Teaching Hospital of Yaoundé. However, this proportion is lower than that found by Engbang et al. in 2015 in the Littoral and N'Dah et al. in 2014 in Côte d'Ivoire, which reached 72.3% and 82.8% respectively [2, 5-7]. This difference could be explained by the fact that the latter authors did not include breast cancer in their series. This high frequency of cervical cancer in our context can be explained by its multiple risk factors including: factors that increase the risk of infection with human papillomavirus (HPV), such as unprotected premature intercourse (under 17 years of age) and multiple sexual partners, multiparity, oral contraceptives and immunodeficiency [8]. It can also be justified by the absence of vaccination against HPV and a cervical cancer screening policy in our context. Indeed, vaccination against HPV serotypes 16 and 18, which are found in 70% of cases of cervical cancer, has been available for of young girls (9-14 years old) in Cameroon since 2014 [1]. Breast cancer was the second most common type of cancer in our series with a proportion of 28.1%, which is similar to that of Sando et al. in 2014 at the Gyneco-Obstetrics and Pediatric Hospital Yaoundé and differs from that of Orock et al. in 2012. In contrast, a study using the cancer registry found that breast cancer is the leading cancer in women [4, 9]. These discordant results raise the issue that, the cancer registry in Cameroon is not fully functional. However, breast cancer is the most prevalent of women's cancers in the world in both developed and developing countries. It accounts for 51% of women's cancers in Burkina Faso, 75.3% in Madagascar, 40.4% of gynecological cancers in Niger [10-12]. Endometrial cancer was third most common cancer in our series, accounting for 9.7%; this result is similar to that of Engbang et al. who found 11.6% in 2015 in the Littoral region of Cameroon and Agboeze et al. found a proportion of 10.1% in Nigeria in 2015 [6, 13]. This proportion, however, is lower than those found in developed countries, especially the 40.1% reported in Japan by Yamagami et al. in 2017 and 45.9% in Turkey according to Gultekin et al. in 2017 [14, 15]. This difference could be explained by the fact that, unlike cervical cancer, where screening methods are known and screening programs are operational and effective in these countries, there is no method of screening for endometrial cancer. For cervical cancer, the mean age was 52.8±13.5 years with extremes of 26 and 82 years; this result was similar to those of Sando et al. in 2014, who had an average age of 52.4±3.8 years for cervical cancer in Yaoundé and Engbang et al. who found 51.2±11.9 years in the Littoral [4, 6]. This result could be explained by the 10-20 year long evolution of the pre-cancerous lesion to invasive cancer and by the lack of a cancer screening program in general in our context. Fewer than half of the patients resided in Yaoundé and more than half were admitted to the University Teaching Hospital Yaoundé by reference. These results can be explained by the reduced number of diagnostic structures across the national territory which are concentrated in the larger metropolitan areas, therefore if there is a suspicion of cancer in a first-level health facility, patients will be conducted to a referral hospital, including the University Teaching Hospital Yaoundé.

Histopathological features of gynecological cancers

Cervical cancer: squamous cell carcinoma was the predominant histological type accounting for 86.8% (158 of 182 cases) followed by adenocarcinoma. This result is consistent with the literature where this proportion varies between 72-94% [2, 4, 6, 10, 14-16]. Breast cancer: cancer: 78.1% (75 of 96) of breast cancers were ductal carcinomas. This result is consistent with the literature, where this proportion varies between 64.9-92.5% [4, 17, 18]. In addition, according to the histopronostic grade, breast cancers were predominantly of intermediate prognosis (grade II), followed by those with a poor prognosis (grade III); this result is similar to those found by Engbang et al. in Cameroon and Belhafiane et al. in Morocco [19, 20]. Endometrial cancer: adenocarcinoma was the most common histologic type of endometrial cancer accounting for 72.2% (26/36) of cases. This result is comparable to those found by Sando et al. at Gyneco-Obstetrics and Pediatric Hospital of Yaoundé (90.50%), N'Dah et al. in Côte d'Ivoire 67,7% and 86.6% by Shahid et al. in Pakistan [2, 4, 21]. These results are explained by the fact that the lining of the endometrium is covered by a simple cylindrical epithelium. Ovarian cancer: epithelial cancers were the most common type of ovarian cancer with 86.7%, with serous cystadenocarcinoma being the most common. This predominance of epithelial cancers has been found in the literature in proportions varying between 68-93% [2, 4, 6, 22, 23]. The predominant histologic type of cancers of the vagina and vulva was squamous cell carcinoma in proportions of 88.9% (8 out of 9) and 100% (3 out of 3), respectively, which corroborates with data from the literature [2, 6]. This result is explained by the fact that same type of epithelium, namely the pluristratified squamous epithelium, covers the mucous membranes of the vagina and vulva.

Conclusion

In this study, we aimed to describe the epidemiological and clinical characteristics of gynecological cancers at the University Teaching Hospital of Yaoundé. Our results indicate that gynecological cancers represent 50.1% of women's cancers and that the most common are cancers of the cervix and breast. Most of the gynecological cancer patients were housewives, multiparous and above 50 years of age. The most common histopathological types were squamous cell carcinoma for cervical cancer and ductal carcinoma for breast cancer. Based on these findings, sensitization should be strengthened and the routine prescription of cervical and breast cancer screening tests should begin at 30 and 40 years of age respectively. Cancer is the third leading cause of death in developing countries; Gynecological cancers account for 54.3% of women's cancers in Africa; There are several histopathological types of gynecological cancers. Calculation of the global and specific frequencies of gynecological and mammary cancers; Description of socio-demographic characteristics of gynecological cancer patients; Determination of the most frequent histopathological types of gynecological cancers.

Competing interests

The authors declare no competing interests.
  10 in total

1.  Gynecological malignancies in Maroua, Cameroon.

Authors:  Pierre-Marie Tebeu; Patrick Petignat; Paulette Mhawech-Fauceglia
Journal:  Int J Gynaecol Obstet       Date:  2008-10-15       Impact factor: 3.561

2.  [Diagnosis and treatment of breast cancer in Cameroon: a series of 65 cases].

Authors:  F Essiben; P Foumane; E T Mboudou; J S Dohbit; V Mve Koh; P Ndom
Journal:  Mali Med       Date:  2013

3.  [Epidemiological and histological aspects of gynecologic and breast cancer in the pathology department of Niamey's Health Faculty, Niger].

Authors:  M Nayama; H Nouhou; K Souna-Madougou; N Idi; M Garba; A Tahirou; A Touré
Journal:  Mali Med       Date:  2006

4.  Epidemiology of breast cancer: retrospective study in the Central African Republic.

Authors:  Augustin Balekouzou; Ping Yin; Christian Maucler Pamatika; Ghose Bishwajit; Sylvain Wilfrid Nambei; Marceline Djeintote; Barbara Esther Ouansaba; Chang Shu; Minghui Yin; Zhen Fu; Tingting Qing; Mingming Yan; Yuanli Chen; Hongyu Li; Zhongyu Xu; Boniface Koffi
Journal:  BMC Public Health       Date:  2016-12-07       Impact factor: 3.295

Review 5.  Clinical statistics of gynecologic cancers in Japan.

Authors:  Wataru Yamagami; Satoru Nagase; Fumiaki Takahashi; Kazuhiko Ino; Toru Hachisuga; Daisuke Aoki; Hidetaka Katabuchi
Journal:  J Gynecol Oncol       Date:  2017-02-10       Impact factor: 4.401

6.  The pattern of gynecological malignancies in 968 cases from Pakistan.

Authors:  Shahid Jamal; Nadira Mamoon; Sajid Mushtaq; Muhammad Luqman; Saleha Moghal
Journal:  Ann Saudi Med       Date:  2006 Sep-Oct       Impact factor: 1.526

7.  [Histo-epidemiological aspects of genital cancers in women in the Littoral Region, Cameroon].

Authors:  Jean Paul Ndamba Engbang; Valère Mve Koh; Charlotte Nguefack Tchente; Amadou Fewou
Journal:  Pan Afr Med J       Date:  2015-06-12

8.  [Profile of breast and gynecological cancers in Yaoundé--Cameroon].

Authors:  Zacharie Sando; Jovanny Tsuala Fouogue; Florent Ymele Fouelifack; Jeanne Hortence Fouedjio; Emile Telesphore Mboudou; Jean Louis Oyono Essame
Journal:  Pan Afr Med J       Date:  2014-01-17

9.  [Breast cancer in Cameroon, histo-epidemiological profile: about 3044 cases].

Authors:  Jean Paul Ndamba Engbang; Henri Essome; Valère Mve Koh; Godefroy Simo; Jean Daniel Sime Essam; Albert Sone Mouelle; Jean Louis Oyono Essame
Journal:  Pan Afr Med J       Date:  2015-08-04

10.  Survival of gynecological cancers in Turkey: where are we at?

Authors:  Murat Gultekin; Selin Dundar; Irem Kucukyildiz; Mujdegul Zayifoglu Karaca; Guledal Boztas; Semra Hatice Turan; Ezgi Hacikamiloglu; Bekir Keskinkilic
Journal:  J Gynecol Oncol       Date:  2017-11       Impact factor: 4.401

  10 in total
  1 in total

1.  Breast Cancer in Togolese Women: Imaging and Clinicopathological Findings.

Authors:  Tchin Darré; Mazamaesso Tchaou; Toukilnan Djiwa; Baguilane Douaguibe; Akila Bassowa; Solange Adani-Ifé; Ayikoé Kossi Amavi; Bidamin N'Timon; Abdoulatif Amadou; Panakinao Simgban; Bingo K N'Bortche; Koffi Amégbor; Abdoul-Samadou Aboubakari; Gado Napo-Koura
Journal:  Breast Cancer (Auckl)       Date:  2021-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.